14,709 Shares in Cibus, Inc. (NASDAQ:CBUS) Acquired by Blair William & Co. IL

Blair William & Co. IL purchased a new position in shares of Cibus, Inc. (NASDAQ:CBUS) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 14,709 shares of the company’s stock, valued at approximately $28,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Two Sigma Investments LP acquired a new position in Cibus during the 4th quarter worth approximately $68,000. Nuveen Asset Management LLC increased its holdings in Cibus by 87.7% during the 4th quarter. Nuveen Asset Management LLC now owns 37,978 shares of the company’s stock worth $106,000 after purchasing an additional 17,744 shares during the last quarter. Granby Capital Management LLC increased its holdings in Cibus by 300.0% during the 4th quarter. Granby Capital Management LLC now owns 200,000 shares of the company’s stock worth $556,000 after purchasing an additional 150,000 shares during the last quarter. Deutsche Bank AG increased its holdings in Cibus by 418.2% during the 4th quarter. Deutsche Bank AG now owns 45,841 shares of the company’s stock worth $127,000 after purchasing an additional 36,995 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in Cibus by 113.4% during the 4th quarter. Bank of America Corp DE now owns 35,536 shares of the company’s stock worth $99,000 after purchasing an additional 18,885 shares during the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.

Cibus Stock Up 3.6%

CBUS stock opened at $1.42 on Thursday. Cibus, Inc. has a 52-week low of $1.36 and a 52-week high of $8.65. The stock’s 50 day moving average is $1.55 and its two-hundred day moving average is $1.99. The company has a market capitalization of $46.38 million, a PE ratio of -0.13 and a beta of 1.75.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group dropped their price objective on Cibus from $18.00 to $17.50 and set a “buy” rating on the stock in a report on Monday, May 12th.

Cibus Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.